STOCK TITAN

Jack Nathan Med Stock Price, News & Analysis

JNHMF OTC

Welcome to our dedicated page for Jack Nathan Med news (Ticker: JNHMF), a resource for investors and traders seeking the latest updates and insights on Jack Nathan Med stock.

Jack Nathan Med (JNHMF) delivers innovative healthcare solutions through advanced medical devices and diagnostic technologies. This news hub provides investors and industry professionals with essential updates about the company's clinical advancements and market position.

Access timely announcements including earnings reports, product launches, regulatory milestones, and partnership developments. Our curated collection ensures you stay informed about JNHMF's contributions to medical imaging systems, therapeutic devices, and diagnostic equipment innovations.

Discover press releases detailing clinical-grade technology deployments and research breakthroughs. All content is verified for accuracy, providing reliable insights into the company's operational strategies and healthcare impact without speculative commentary.

Bookmark this page for streamlined access to JNHMF's evolving story in the medtech sector. Regularly updated with official communications, it serves as your primary resource for understanding the company's role in shaping modern clinical solutions.

Rhea-AI Summary

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) reported significant growth in its Q1-Fiscal 2023 financial results, with total revenues increasing by 207% year-over-year to $3,893,322. The clinic operations revenue surged 632% to $3,145,191, attributed to recent acquisitions and easing pandemic restrictions. Despite a narrowed operating loss of $1,258,176, total operating expenses rose to $5,151,498. The company aims to expand its footprint with a new financing arrangement with Walmart Canada and plans to open up to 13 new clinics in 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.64%
Tags
-
Rhea-AI Summary

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) reported Q4 FY2022 revenues of $4.0 million, a significant increase of 461% from Q4 FY2021. For the fiscal year, total revenues reached $9.6 million, up 150% year-over-year. The Company acquired 5 profitable clinics in British Columbia, estimated to generate annual revenues of $5 million. However, operating expenses rose sharply to $5.99 million in Q4, leading to a loss from operations of $1.97 million. Despite challenges, the Company anticipates continued growth in 2022 through clinic expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) has announced a new Credit Facility and licensed locations aimed at expanding its network of medical clinics across Canada, particularly within Walmart Canada stores. The agreement will finance the construction of eleven new clinics slated for 2022, with plans for further expansion. This strategic partnership emphasizes the commitment to enhancing healthcare accessibility for millions of Canadians. Jack Nathan currently operates 76 clinics in Walmart, tapping into Walmart's extensive network of 402 stores.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Jack Nathan Medical Corp. (JNHMF) reported Q3 fiscal 2022 revenues of $2.4 million, up 143% year-over-year. The company expanded its footprint to over 190 medical clinics, a 130% increase from the previous year. Despite significant growth, operating expenses rose to $4.5 million, leading to a loss of $2.1 million from operations. Following a strategic change, JNH is consolidating its clinic operations in Mexico from 115 to 78 locations, aiming for improved profitability. The company holds $2.7 million in cash and plans to leverage recent acquisitions for continued growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Jack Nathan Health is set to engage with investors through a live presentation on VirtualInvestorConferences.com on December 16, 2021, at 1:30 PM ET. CEO Dr. Glenn Copeland and CFO David Berman will share insights about the company's healthcare network, which operates primary care clinics in Walmart stores across Canada and Mexico. Investors can participate in real-time Q&A and access an archived version post-event. Jack Nathan Health aims to improve medical access through their innovative clinic model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.38%
Tags
conferences
-
Rhea-AI Summary

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) has announced the appointment of Marcy Herriman as the new Chief Operating Officer (COO), effective immediately. Herriman, who joined the company in 2020 as Vice President of Clinic Operations, has extensive experience in medical operations and business development. Dr. Glenn Copeland, CEO, expressed confidence in her leadership and contributions to the company's expansion. Under her guidance, Jack Nathan Health aims to strengthen its presence and services in Canada and Mexico, positioned for growth despite the challenges posed by the COVID-19 pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) has announced the acquisition of five profitable medical clinics in British Columbia, projected to add over $5.0 million in annualized revenue. This strategic acquisition enhances JNH's operational footprint, bringing the total to 15 corporate-owned clinics across Canada. The company aims to convert licensed clinics into corporate centers to maximize revenue potential and expand services. The transaction includes an initial $525,000 cash payment and share issuances tied to performance metrics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) will participate in the Canaccord Genuity 3rd Annual Health and Wellness Conference on November 16, 2021, at 8:30 AM Eastern Time. The event will be virtual, with CEO Dr. Glenn Copeland and CFO David Berman discussing the company's expansion of medical clinics in Canada and Mexico. Currently, it operates 76 clinics in Canada and plans to open three more while expanding its 115 clinics in Mexico with 88 additional sites expected in 2022. The conference addresses key themes in the health sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
conferences
-
Rhea-AI Summary

Jack Nathan Medical Corp. (JNHMF) reported a 70% increase in Q2 fiscal 2022 revenues, reaching approximately $1.9 million. The company expanded its medical clinic network to 146 locations, a 76% increase from the previous year. Notably, the 100th clinic opened in Mexico, with plans to reach 203 by fiscal year-end. A new COVID-19 testing program in collaboration with Walmart Mexico has launched, operating at 28 sites. However, the company reported a loss from operations of approximately $1.9 million due to increased operating expenses amidst expansion efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) is launching a new COVID-19 testing program in Mexico, opening three initial testing centers at Walmart locations this week. The company plans to establish a total of 28 sites, with authorization for 20 from the Mexican government. The testing will provide rapid antigen tests at a cost 70% lower than typical pricing, improving healthcare access. Currently, JNH operates 52 clinics in Mexico and aims to expand to 203 clinics by the end of the year, enhancing healthcare delivery within Walmart stores.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
covid-19

FAQ

What is the current stock price of Jack Nathan Med (JNHMF)?

The current stock price of Jack Nathan Med (JNHMF) is $0.0104 as of August 20, 2025.

What is the market cap of Jack Nathan Med (JNHMF)?

The market cap of Jack Nathan Med (JNHMF) is approximately 871.0K.
Jack Nathan Med

OTC:JNHMF

JNHMF Rankings

JNHMF Stock Data

870.99k
55.51M
36.27%
Medical Care Facilities
Healthcare
Canada
Woodbridge